These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8971424)

  • 21. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition model.
    Raut A; Dhapare S; Venitz J; Sakagami M
    Biopharm Drug Dispos; 2020 Feb; 41(1-2):32-43. PubMed ID: 31691979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing delivery of inhaled corticosteroids: matching drugs with devices.
    O'Riordan TG
    J Aerosol Med; 2002; 15(3):245-50. PubMed ID: 12396412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.
    Moustafa IOF; Ali MRA; Al Hallag M; Rabea H; Fink JB; Dailey P; Abdelrahim MEA
    Heart Lung; 2017; 46(6):464-467. PubMed ID: 28882385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pulmonary absorption using pharmacokinetic methods.
    Derendorf H; Hochhaus G; Möllmann H
    J Aerosol Med; 2001; 14 Suppl 1():S9-17. PubMed ID: 11424896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches.
    Soulele K; Macheras P; Karalis V
    Pulm Pharmacol Ther; 2018 Feb; 48():168-178. PubMed ID: 29223508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.
    Lipworth BJ; Jackson CM
    Drug Saf; 2000 Jul; 23(1):11-33. PubMed ID: 10915030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids.
    Padden J; Skoner D; Hochhaus G
    J Asthma; 2008; 45 Suppl 1():13-24. PubMed ID: 19093281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI
    J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absolute oral versus inhaled bioavailability: significance for inhaled drugs with special reference to inhaled glucocorticoids.
    Rohatagi S; Rhodes GR; Chaikin P
    J Clin Pharmacol; 1999 Jul; 39(7):661-3. PubMed ID: 10392319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.
    Hu X; Yang FF; Liao YH
    Curr Pharm Des; 2016; 22(17):2532-48. PubMed ID: 26818873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.
    Sullivan BP; El-Gendy N; Kuehl C; Berkland C
    Mol Pharm; 2015 Aug; 12(8):2665-74. PubMed ID: 25915095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
    Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
    Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma.
    Brocklebank D; Wright J; Cates C
    BMJ; 2001 Oct; 323(7318):896-900. PubMed ID: 11668133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers.
    Cass LM; Brown J; Pickford M; Fayinka S; Newman SP; Johansson CJ; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():21-31. PubMed ID: 10429837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
    Dahlström K; Thorsson L; Larsson P; Nikander K
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation.
    ElHansy MHE; Boules ME; El Essawy AFM; Al-Kholy MB; Abdelrahman MM; Said ASA; Hussein RRS; Abdelrahim ME
    Pulm Pharmacol Ther; 2017 Aug; 45():159-163. PubMed ID: 28627376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.